MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's disease

MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's disease

Abstract Introduction Alzheimer's disease (AD) lacks a less invasive and early detectable biomarker. Here, we investigated the biomarker potential of miR‐501‐3p and miR‐502‐3p using different AD sources. Methods MiR‐501‐3p and miR‐502‐3p expressions were evaluated in AD cerebrospinal fluid (CSF...

Full description

Saved in:
Bibliographic Details
Main Authors: Davin Devara, Bhupender Sharma, Gunjan Goyal, Daniela Rodarte, Aditi Kulkarni, Nathan Tinu, Ayana Pai, Subodh Kumar
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Clinical and Translational Medicine
Subjects:
Alzheimer's disease
biomarker
CSF
MiR‐501‐3p
MiR‐502‐3p
serum
Online Access:https://doi.org/10.1002/ctm2.70389
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ctm2.70389

Similar Items